Episode 24: A Between the Biotech Waves conversation with John Hoffman, managing director & head of healthcare equity capital markets at Credit Suisse
Between the Biotech Waves
00:00
The Reverse of the Biotech Sector
The third was if you look at the broadband to see and just the constituents and how spend actually tracked, it was effectively flat, maybe slightly up. So we hadn't seen it in the aggregate numbers, but I think we would absolutely see it on a case-by-case basis. What are the indicators that it is? Get back into bed, pull the covers up over your head, and wait for 2024. Gen1 2024.
Play episode from 45:35
Transcript
